Shares of BeiGene, Ltd. (BGNE) have gained 28.8% over the past four weeks to close the last trading session at $202.17, but there could still be a solid upside left in the stock if short-term price targets of Wall Street analysts are any indication. Going by the price targets, the mean estimate of$258.45 indicates a potential upside of 27.8%.The mean estimate comprises 11 short-term price targets with a standard deviation of $55.54. While the lowest estimate of$152 indicates a 24.8% decline from the curre ...